We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$403M
AUM Growth
-$4.68M
Cap. Flow
-$2.76M
Cap. Flow %
-0.68%
Top 10 Hldgs %
28.94%
Holding
118
New
3
Increased
17
Reduced
54
Closed
2

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.56M
2
ADBE icon
Adobe
ADBE
+$1.61M
3
TSLA icon
Tesla
TSLA
+$422K
4
AFL icon
Aflac
AFL
+$199K
5
WEC icon
WEC Energy
WEC
+$194K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.52M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.09M
3
QRVO icon
Qorvo
QRVO
+$877K
4
ABT icon
Abbott
ABT
+$388K
5
JPM icon
JPMorgan Chase
JPM
+$326K

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Consumer Staples 11.95%
3 Healthcare 11.84%
4 Financials 10.61%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
51
ConocoPhillips
COP
$141B
$3.52M 0.87%
33,518
+734
+2% +$73.2K
LLY icon
52
Eli Lilly
LLY
$1.04T
$3.46M 0.86%
4,188
VTI icon
53
Vanguard Morningstar Total Stock Market ETF
VTI
$682B
$3.4M 0.84%
12,380
HD icon
54
Home Depot
HD
$351B
$3.23M 0.8%
8,805
IAU icon
55
iShares Gold Trust
IAU
$65.8B
$2.96M 0.73%
50,143
-140
-0.3% -$7.57K
IJH icon
56
iShares Core S&P Mid-Cap ETF
IJH
$126B
$2.85M 0.71%
48,799
-441
-0.9% -$27.4K
HYG icon
57
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.54M 0.63%
32,269
-866
-3% -$68.7K
VB icon
58
Vanguard Morningstar Small-Cap ETF
VB
$81.9B
$2.26M 0.56%
10,191
-78
-0.8% -$18.6K
BBH icon
59
VanEck Biotech ETF
BBH
$408M
$1.78M 0.44%
11,311
-370
-3% -$60.1K
SYK icon
60
Stryker
SYK
$128B
$1.62M 0.4%
4,354
JNJ icon
61
Johnson & Johnson
JNJ
$622B
$1.6M 0.4%
9,661
IBB icon
62
iShares Biotechnology ETF
IBB
$9.48B
$1.52M 0.38%
11,927
-630
-5% -$85.4K
GOOG icon
63
Alphabet (Google) Class C
GOOG
$4.41T
$1.51M 0.37%
9,650
-380
-4% -$69.6K
CVX icon
64
Chevron
CVX
$373B
$1.44M 0.36%
8,608
ORCL icon
65
Oracle
ORCL
$417B
$1.42M 0.35%
10,154
-105
-1% -$17.1K
DIA icon
66
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.9B
$1.41M 0.35%
3,367
CAT icon
67
Caterpillar
CAT
$412B
$1.17M 0.29%
3,542
PAYX icon
68
Paychex
PAYX
$41.6B
$1.17M 0.29%
7,555
-35
-0.5% -$5.15K
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$68.1B
$1.16M 0.29%
19,063
-2,230
-10% -$134K
VEA icon
70
Vanguard FTSE Developed Markets ETF
VEA
$235B
$1.07M 0.27%
20,994
-1,005
-5% -$50.9K
HYD icon
71
VanEck High Yield Muni ETF
HYD
$4.44B
$918K 0.23%
17,938
-1,181
-6% -$61.2K
IBM icon
72
IBM
IBM
$223B
$799K 0.2%
3,213
WM icon
73
Waste Management
WM
$89.2B
$715K 0.18%
3,090
VWO icon
74
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$681K 0.17%
15,048
-1,099
-7% -$49.5K
YUM icon
75
Yum! Brands
YUM
$41.5B
$679K 0.17%
4,320

Similar funds

Boston Research & Management's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Research & Management held 118 positions worth $403M, down 1.1% from $407M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 2, leaving the 118-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q1 2025 buy was Tesla: 1,265 shares worth $327K.
  • Boston Research & Management added most to NVIDIA in Q1 2025, an estimated $3.56M increase.
  • Boston Research & Management's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.09M.
  • Boston Research & Management fully exited CVS Health in Q1 2025, selling an estimated $1.52M.
  • Boston Research & Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2025.
  • Boston Research & Management opened 3 new positions and closed 2 in Q1 2025.
  • Boston Research & Management's portfolio value fell 1.1% quarter-over-quarter to $403M.

Based on Boston Research & Management's 13F filing for Q1 2025, filed 12 May 2025.